Recombinant Human Nerve Growth Factor class drugs

1 result
Dompé farmaceutici S.p.A.
Usage: OXERVATE (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.